Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye

ClinicalTrials.gov ID: NCT02815293

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02815293. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:37 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objectives of this study are twofold * To evaluate the safety and efficacy of 0.1% AGN-195263 administered twice daily compared to its vehicle in patients with evaporative dry eye (EDE) * To evaluate the systemic pharmacokinetics of 0.1% AGN-195263 administered twice daily in patients with EDE

Study identification

NCT ID
NCT02815293
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Allergan
Industry
Enrollment
36 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2016 (Actual)
Primary completion
Jun 21, 2017 (Actual)
Completion
Jun 21, 2017 (Actual)
Last update posted
Feb 19, 2019

2016 – 2017

United States locations

U.S. sites
29
U.S. states
15
U.S. cities
29
Facility City State ZIP Site status
Arizona Eye Center Chandler Arizona 85225 —
Clearsight Fullerton California 92835 —
Orange County Ophthalmology Medical Group Garden Grove California 92843 —
Montebello Medical Center, Inc. Montebello California 90640 —
Eye Research Foundation Newport Beach California 92663 —
North Bay Eye Associates Petaluma California 94954 —
Martel Eye Medical Group Rancho Cordova California 95670 —
Centennial Eye and Cosmetic Associates Centennial Colorado 80016 —
Specialty Eye Care Parker Colorado 80134 —
Argus Research at Cape Coral Eye Center Cape Coral Florida 33904 —
Sarasota Retina Institute Sarasota Florida 34239 —
Eye Care Centers Management, Inc. dba Clayton Eye Center Morrow Georgia 30260 —
Taustine Eye Center Louisville Kentucky 40217 —
Eye Doctors of Washington Chevy Chase Maryland 20815 —
Mercy Medical Research Institute Springfield Missouri 65804 —
Ophthalmology Consultants, Ltd St Louis Missouri 63131 —
Comprehensive Eye Care Washington Missouri 63090 —
Cornerstone Eye Care, LLC High Point North Carolina 27262 —
University Hospitals of Cleveland Cleveland Ohio 44106 —
Carolina Macula and Retina Mt. Pleasant South Carolina 29464 —
Nashville Vision Associates, LLC Nashville Tennessee 37205 —
Robert Cizik Eye Clinic Houston Texas 77030 —
Houston Eye Associates Kingwood Texas 77339 —
Brazosport Eye Institute Lake Jackson Texas 77566 —
The Eye Clinic of Texas, an affiliate of Houston Eye Associates League City Texas 77573 —
DCT- Shah Research, LLC dba Discovery Clinical Trials Mission Texas 78572 —
R and R Eye Research, LLC San Antonio Texas 78229 —
Stacy R. Smith, M.D., P.C. Salt Lake City Utah 84117 —
The Eye Centers of Racine and Kenosha Racine Wisconsin 53405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02815293, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 19, 2019 · Synced Nov 15, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.